UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Alvedon 500 mg Brustablett
- Invented name part: Alvedon
- Strength part: 500 mg
- Pharmaceutical dose form part: brustablett
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Effervescent tablet
Legal status of supply: Medicinal product subject to medical prescription exempt for some pack sizes
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 9068
Region: Kingdom of Sweden
Marketing authorisation holder: GlaxoSmithKline Consumer Healthcare ApS
Identifier:
Status: Valid (1975-06-13)
Package 1 of 2
PCID:
Description: Rör, 20 brustabletter
Marketing status:
Pack size:
Package: 1 Tablet tube (Plastic)
Containing: 20 Tablet
Manufactured Item
Dose form: Effervescent tablet
Unit of presentation: Tablet
Ingredient
Role: Active
Substance: Paracetamol
Presentation strength: 500 milligram(s) / 1 Tablet
Reference strength: Paracetamol 500 milligram(s) / 1 Tablet
Package 2 of 2
PCID:
Description: Rör, 90 (3 x 30) brustabletter
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 3 Tablet tube (Plastic)
Containing: 30 Tablet
Manufactured Item
Dose form: Effervescent tablet
Unit of presentation: Tablet
Ingredient
Role: Active
Substance: Paracetamol
Presentation strength: 500 milligram(s) / 1 Tablet
Reference strength: Paracetamol 500 milligram(s) / 1 Tablet
Administrable Product (1 of 1)
Dose form: Oral solution
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: Paracetamol
Presentation strength: 500 milligram(s) / 1 Tablet
Reference strength: Paracetamol 500 milligram(s) / 1 Tablet